Navigation Links
Webcast Alert: Oxygen Biotherapeutics, Inc. Investor Meeting in Zurich, Switzerland
Date:3/30/2009

COSTA MESA, Calif., March 30 /PRNewswire-FirstCall/ -- Oxygen Biotherapeutics, Inc. (OTC Bulletin Board: OXBO) will hold an investor presentation meeting for shareholders, prospective investors and interested parties in Zurich, Switzerland on April 1, 2009. The purpose of the meeting will be to update the investment community on the company's business.

Company chairman and CEO Chris J. Stern will be available to answer shareholder questions along with the co-chairs of the company's medical advisory board, Dr. Bruce D. Spiess, M.D., FAHA - Professor Anesthesiology and Emergency Medicine, VCURES/ VCU Med Center Richmond, Virginia and Dr. Ross Bullock, M.D. Ph.D.- Professor of Neurosurgery, University of Miami, Miami, Florida.

The three will be in Switzerland in connection with the clinical investigator meeting, a formal initiating step for the Swiss Phase II clinical trial of Oxycyte(R) in traumatic brain injury. Oxycyte is the Company's perfluorocarbon (PFC) therapeutic oxygen carrier.

The meeting will be webcast live with the webcast available via the investor relations page of the company website.

    Meeting details are as follows:
          Location:   Radisson SAS Zurich Airport Hotel
          Time:       1:00 p.m. - 3:00 p.m. local time (7:00 a.m. - 9:00
                      a.m. eastern time)
          Language:   The meeting language will be English

"This will give European investors a chance to participate in a discussion with management and key researchers," said Stern. "We are also planning a meeting of this type in the U.S. later this year."

    What:     Live webcast of Zurich Investor Meeting

    When:     April 1, 2009 at 1:00 p.m. Zurich time (7:00 a.m. EDT)

    Where:    The live webcast will be available via the investor relations
              page of the company website at www.Oxybiomed.com or directly
              at:http://www.videonewswire.com/event.asp?id=57069

    How:      Live over the Internet -- Simply log on to the web at the
              address above.

    Contact:  Abe Wischnia of Abe Wischnia & Associates at 619-795-2345

About Oxygen Biotherapeutics, Inc.

Oxygen Biotherapeutics, Inc. is dedicated to commercializing innovative pharmaceuticals and medical devices in the field of oxygen therapeutics and continuous substrate monitoring. The company has under development a perfluorocarbon therapeutic oxygen carrier and liquid ventilation product (Oxycyte(R)) and an implantable glucose sensor. These products are based upon core technologies that include biomedical applications for PFCs and medical and industrial applications for biosensors. Each of the product candidates is designed with advantages over currently marketed products in major markets including traumatic brain injury, sickle cell crisis pain, trauma, wound care, acute respiratory distress syndrome, stroke, myocardial infarction, surgery, and diabetes. More information is available at www.oxybiomed.com.

Minimum Requirements to listen to broadcast:

The Windows Media Player software, downloadable free from

http://www.microsoft.com and at least a 56Kbps connection to the Internet.

If you experience problems listening to the webcast, send an E-mail to: webcast@multivu.com.


'/>"/>
SOURCE Oxygen Biotherapeutics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Anesiva to Host Conference Call and Webcast Tomorrow to Discuss Encouraging Development in Zingo(TM) Program
2. Caliper Life Sciences Presentation at Thomas Weisel Partners Healthcare Conference to be Webcast
3. Thomas Weisel Partners 2007 Healthcare Conference To Webcast Millennium Presentation
4. deCODE genetics to Webcast Presentation at Thomas Weisel Partners Annual Healthcare Conference
5. Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Thomas Weisel Partners Conference
6. Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at BioCentury-Thomson Financial Investment Conference
7. Volcano Corporation Presentation at Bear Stearns Conference to be Webcast
8. Telik Announces Presentation and Webcast at Bear Stearns Healthcare Conference
9. ZymoGenetics to Webcast Presentation at Two Upcoming Conferences
10. MIGENIX First Fiscal Quarter 2008 Financial Results Conference Call & Webcast Notification
11. Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Bear Stearns Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2017)... ... ... The AMA is happy to announce that $48,000 in scholarships will be ... are created through funds donated by model aviation organizations and individuals, AMA members, and ... Scholarship Committee, which is made up of model aviation pilots and enthusiasts. The committee ...
(Date:4/20/2017)... ... April 20, 2017 , ... Assured Enterprises, Inc. ... offer a full spectrum of digital security goods and services. The strategic partners ... the ground-breaking proactive cybersecurity services and products through Assured Enterprises. The two companies ...
(Date:4/20/2017)... Hong Kong (PRWEB) , ... April 20, 2017 , ... ... for Global Sales. , With over 20 years of experience in the learning technologies ... LEO, a sister company within Learning Technologies Group plc (LTG). At LEO, Mastin served ...
(Date:4/20/2017)... and Bethesda, MD (PRWEB) , ... April 20, ... ... Innovation announce the formation of a unique intellectual property (IP) sharing and commercialization ... of their most promising inventions. A main component of this effort is bringing ...
Breaking Biology Technology:
(Date:4/5/2017)... -- The Allen Institute for Cell Science today announces the ... and dynamic digital window into the human cell. The ... of deep learning to create predictive models of cell ... growing suite of powerful tools. The Allen Cell Explorer ... available resources created and shared by the Allen Institute ...
(Date:4/3/2017)... WASHINGTON , April 3, 2017 /PRNewswire-USNewswire/ ... single-cell precision engineering platform, detected a statistically ... cell product prior to treatment and objective ... highlight the potential to predict whether cancer ... prior to treatment, as well as to ...
(Date:3/29/2017)... March 29, 2017  higi, the health IT company ... North America , today announced a Series ... acquisition of EveryMove. The new investment and acquisition accelerates ... tools to transform population health activities through the collection ... higi collects and secures data today on ...
Breaking Biology News(10 mins):